ATAIBECKLEY INC (ATAI) — insider trading
Health Care · NASDAQ
ATAIBECKLEY INC (ATAI) has 27 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 27 (latest 2026-07-07).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | HERSHBERG ROBERT | Director | Option exercise / conversion (derivative) | 51,142 | $0.00 | $0 | Form 4 |
| 2026-07-07 | HERSHBERG ROBERT | Director | Option exercise / conversion (derivative) | 48,858 | $0.00 | $0 | Form 4 |
| 2026-07-07 | HERSHBERG ROBERT | Director | Open-market sale | 100,000 | $4.96 | $496.0K | Form 4 |
| 2026-07-07 | HERSHBERG ROBERT | Director | Option exercise / conversion | 51,142 | $1.35 | $69.0K | Form 4 |
| 2026-07-07 | HERSHBERG ROBERT | Director | Option exercise / conversion | 48,858 | $1.35 | $66.0K | Form 4 |
| 2026-06-26 | Kochendoerfer Gerd | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 50,000 | $0.00 | $0 | Form 4 |
| 2026-06-26 | Kochendoerfer Gerd | Officer (Chief Operating Officer) | Open-market sale | 50,000 | $5.00 | $250.0K | Form 4 |
| 2026-06-26 | Kochendoerfer Gerd | Officer (Chief Operating Officer) | Option exercise / conversion | 50,000 | $1.60 | $80.0K | Form 4 |
| 2026-06-25 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 9,528 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 33,051 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Craig Kevin James | Officer (Chief Medical Officer) | Open-market sale | 42,579 | $4.51 | $192.0K | Form 4 |
| 2026-06-25 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion | 9,528 | $1.18 | $11.2K | Form 4 |
| 2026-06-25 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion | 33,051 | $1.50 | $49.6K | Form 4 |
| 2026-06-04 | JOHNSON SABRINA MARTUCCI | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Smiley Andrea Heslin | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Kalali Amir H | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Hoffman John Francis | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | HERSHBERG ROBERT | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Fischer Laurent | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Braunstein Scott | Director | Grant / award / vesting (derivative) | 86,095 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Braunstein Scott | Director | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-06-04 | Angermayer Christian | Director, 10% owner | Grant / award / vesting (derivative) | 121,968 | $0.00 | $0 | Form 4 |
| 2026-04-20 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 15,299 | $0.00 | $0 | Form 4 |
| 2026-04-20 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 27,280 | $0.00 | $0 | Form 4 |
| 2026-04-20 | Craig Kevin James | Officer (Chief Medical Officer) | Open-market sale | 42,579 | $5.00 | $212.9K | Form 4 |
| 2026-04-20 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion | 15,299 | $1.84 | $28.2K | Form 4 |
| 2026-04-20 | Craig Kevin James | Officer (Chief Medical Officer) | Option exercise / conversion | 27,280 | $1.50 | $40.9K | Form 4 |
Ask the chat about ATAI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ATAIBECKLEY INC (ATAI).
Last updated 2026-07-07 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.